Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Taltirelin, TRHR, and TH in Parkinson’s Models
2026-08-19
Zhu et al. identify a previously underdefined mechanism by which the long-acting TRH analog Taltirelin promotes TH expression in striatal medium spiny neurons through TRHR-MAPK-RARα-DRD2 signaling. The findings refine how Taltirelin may improve dopaminergic function in Parkinson’s disease models while clarifying that TH induction in the striatum is not equivalent to replacing lost midbrain dopaminergic neurons.
-
PTH (1-34) Across Bone and Kidney Models
2026-08-18
A translational framework for using Parathyroid hormone (1-34) (human) to connect receptor pharmacology, bone metabolism research, serum calcium regulation, and spatially organized kidney assembloids.
-
Simulation-Guided LNP Size Control for mRNA Delivery
2026-08-18
This study combines computational fluid dynamics with microfluidic formulation to isolate lipid nanoparticle size as a design variable while holding lipid ratios constant. Across in vitro and in vivo models, smaller mRNA-loaded nanoparticles generally produced greater cellular uptake and expression, showing how simulation-guided flow control can support more reproducible delivery studies.
-
Salinomycin: Ion Flux Meets HCC Biology
2026-08-17
Salinomycin is a polyether ionophore antibiotic whose ion-transport activity connects calcium dysregulation with Wnt/β-catenin signaling, transporter biology, and apoptosis in hepatocellular carcinoma research. This article presents an assay-centered framework for separating cytostatic effects from genuine cancer cell death while addressing ionophore toxicity and translational limits.
-
Salvianolic acid B for Fibrosis Assays
2026-08-17
Build pulmonary fibrosis workflows around Salvianolic acid B by pairing LH2/PLOD2 measurements with collagen-remodeling and cell-state readouts. This practical guide covers dosing, controls, matrix assays, assay-interference checks, and troubleshooting for a natural product for fibrosis studies.
-
Flavopiridol: CDK Inhibition Under ER Stress
2026-08-16
Flavopiridol and its synonym L868275 provide a powerful framework for studying CDK-driven proliferation alongside endoplasmic reticulum stress. This article translates intestinal stem-cell findings into practical assay decisions for cancer research while defining the limits of cross-domain interpretation.
-
Guanabenz Acetate in Reliable Cell Assays
2026-08-15
This scenario-driven guide explains how Guanabenz Acetate, SKU B1335, can improve control of solvent effects, receptor-dependent responses, and interpretation in cell viability, proliferation, and cytotoxicity workflows. It combines product-specific formulation data with evidence from stress-response research to support reproducible experimental design without overstating translational conclusions.
-
Carbenoxolone disodium: Practical Protocol Guide
2026-08-14
Carbenoxolone disodium is a research tool for probing 11β-hydroxysteroid dehydrogenase activity, glucocorticoid signaling, and gap junction communication in cell and tissue assays. It is best used with vehicle, viability, and pathway-specific controls, and should not be treated as a selective in vivo efficacy agent when off-target effects cannot be separated.
-
Tumor-Resident Mast Cells Drive Breast Cancer Progression
2026-08-14
This study identifies tumor-resident mast cells as a transcriptionally distinct, pro-tumorigenic immune population in breast cancer. Its experiments define a reciprocal IFNB1–SCF signaling loop that activates the IFNAR1–STAT1 axis, expands ALDH-positive breast cancer stem cells, and links mast-cell state to unfavorable clinical outcomes.
-
Nigericin: A pH-Gradient Assay Strategy
2026-08-13
Nigericin is a potassium/hydrogen ion carrier that converts ion-gradient biology into measurable changes in intracellular pH, mitochondrial function, and cell fate. This article develops an assay-centered framework connecting Nigericin ionophore mechanism with metabolic insights from antibiotic-resistance research without overstating cross-domain evidence.
-
Amplex Red Assay for Autotaxin Inhibitor Profiling
2026-08-13
The 2025 STAR Protocols study standardizes a coupled fluorescence assay for screening and characterizing autotaxin inhibitors. Its staged workflow connects initial hit identification with IC50 analysis, false-positive exclusion, kinetic modeling, and inhibition-mode assignment.
-
3-Methyladenine: Autophagy and PI3K Guide
2026-08-12
3-Methyladenine, also called 3-MA, is a research inhibitor used to interrogate class III phosphoinositide 3-kinase signaling and autophagy. Its transient class III PI3K inhibition, persistent class I PI3K blockade, and supplier-reported Vps34 and PI3Kγ potency values make exposure time and controls central to interpretation.
-
Salvianolic acid B: Assay Design for Fibrosis
2026-08-12
Salvianolic acid B, also known as Dan Shen Suan B, offers a mechanistically informative approach to pulmonary fibrosis research. This article explains how to distinguish LH2 expression effects from downstream collagen remodeling and design assays that connect molecular changes with fibrotic phenotype.
-
Relative Versus Fractional Viability in Cancer Drug Testing
2026-08-11
Hannah Schwartz’s dissertation shows that relative viability and fractional viability capture different components of anticancer drug response: proliferative arrest and cell killing. Its central practical contribution is a framework for interpreting both response magnitude and timing, improving how tumor cell growth inhibition is evaluated in vitro.
-
SCP4, H3T3 Dephosphorylation, and Chromosome Stability
2026-08-11
The reference study identifies SCP4 as a nuclear phosphatase that removes mitotic H3T3 phosphorylation and helps control chromosomal passenger complex recruitment. Cell-based and mouse-zygote evidence connects disrupted SCP4 activity with chromosome missegregation, aneuploidy, and early embryonic mitotic failure.